Skip to main content
. Author manuscript; available in PMC: 2019 Apr 4.
Published in final edited form as: Ann Intern Med. 2018 May 1;168(11):757–765. doi: 10.7326/M17-3008

Table 1.

Characteristics of Study Population*

Characteristic Women With
Screen-Detected
Invasive Cancer
(n = 1609)
Women With
Interval Invasive
Cancer (n = 351)
Matched Control
Participants
(n = 4409)

Mean age (SD), y   60.2 (11.8) 56.6(12.2)    59.6 (11.8)
Mean body mass index (SD), kg/m2   26.9 (5.9) 24.1 (4.6)    26.4 (6)
Median dense breast volume (IQR), ml   57.6 (41.4–80.5) 67.0(45.9–97.8)    51.5 (37.7–71.4)
Family history of breast cancer, n (%)§   448 (28.2) 110(31.3)    837 (19)
 History of breast biopsy, n (%)   358 (22.4)   99 (28.4)    788 (17.9)
Race/ethnicity, n (%)
 White 1248 (77.6) 263 (74.9)  3526 (80)
 Asian   225 (14)   61 (17.4)    570 (12.9)
 Black     45 (2.8)     4(1.1)     89 (2)
 Hispanic     36 (2.2)     8 (2.3)    110(2.5)
 Other     55 (3.4)   15 (4.3)    114(2.6)
Clinical BI-RADS density, n (%)
 Almost entirely fatty   207 (12.9)   19 (5.4)    801 (18.2)
 Scattered fibroglandular densities   650 (40.4)   74(21.1)  1764(40)
 Heterogeneously dense   578 (35.9) 160 (45.6)  1469 (33.3)
 Extremely dense   174(10.8)   98 (27.9)    375 (8.5)
Automated BI-RADS density, n (%)
 Almost entirely fatty   296 (18.4)   23 (6.6)    967 (21.9)
 Scattered fibroglandular densities   536 (33.3)   61 (17.4)  1395 (31.6)
 Heterogeneously dense   522 (32.4) 116(33)  1353 (30.7)
 Extremely dense   255 (15.8) 151 (43)    694(15.7)
BCSC 5-y risk, n (%)
 Low (0%−0.99%)   387 (24.1)   79 (22.5)  1373 (31.1)
 Average (1.00%−1.66%)   446 (27.7)   84 (23.9)  1210 (27.4)
 Intermediate (1.67%−2.49%)   399 (24.8)   93 (26.5)  1110(25.2)
 High (2.50%−3.99%)   282 (17.5)   68 (19.4)    528 (12)
 Very high (≥4.00%)     95 (5.9)   27 (7.7)    188 (4.3)

BCSC = Breast Cancer Surveillance Consortium; BI-RADS = Breast Imaging Reporting and Data System; IQR = interquartile range.

*

Percentages may not sum to 100 due to rounding.

Data missing for 73 participants (1.1%).

Measured with Volpara software (Volpara Solutions).

§

Defined as having a mother, sister, or daughter with breast cancer. Data missing for 35 participants (0.6%).

Data missing for 17 participants (0.3%).